• Ever wanted an RSS feed of all your favorite gaming news sites? Go check out our new Gaming Headlines feed! Read more about it here.
Status
Not open for further replies.

Taka

Member
Apr 27, 2018
989
The saga continues.

Canada's National Advisory Committee on Immunization (NACI) is expected to recommend today a pause in the use of the AstraZeneca-Oxford COVID-19 vaccine on those under the age of 55 because of safety concerns, sources told CBC News.

The updated guidelines will be issued later today, according to sources who spoke on the condition of anonymity. The expected change comes following reports of rare blood clots in some immunized patients.

Canada is expected to receive 1.5 million doses of this product from the U.S. on Tuesday.
Health Canada has said it is aware that researchers in Europe have indicated that they have identified a possible cause for these very rare events, but says little information is available about the findings.

"We have been discussing the rare reports of blood clots and low platelet counts with the European Medicines Agency and other regulators," Dr. Supriya Sharma, Canada's chief medical adviser, said on Thursday. "Health Canada will make decisions for Canada based on the science and evidence.

"This is just the latest issue the company has faced over the last three months.


Right when the US doses will be arriving in Canada too.

globalnews.ca

Canada to get 3.3M vaccine doses this week, including shots on loan from U.S. - National | Globalnews.ca

The 1.5 million doses of the AstraZeneca vaccine from the United States will represent the first to come from south of the border.
 
Status
Not open for further replies.